We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThrogmorton Trust Regulatory News (THRG)

Share Price Information for Throgmorton Trust (THRG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 592.00
Bid: 589.00
Ask: 591.00
Change: 6.00 (1.02%)
Spread: 2.00 (0.34%)
Open: 588.00
High: 592.00
Low: 586.00
Prev. Close: 586.00
THRG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

24 Sep 2021 13:54

BlackRock Throgmorton Trust Plc - Portfolio Update

BlackRock Throgmorton Trust Plc - Portfolio Update

PR Newswire

London, September 24

The information contained in this release was correct as at 31 August 2021. Information on the Company’s up to date net asset values can be found on the London Stock Exchange Website at:

https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html

BLACKROCK THROGMORTON TRUST PLC (LEI: 5493003B7ETS1JEDPF59) 

All information is at 31 August 2021 and unaudited.Performance at month end is calculated on a cum income basis

One Month %Three months %One year %Three years %Five years %
Net asset value6.014.167.371.6174.8
Share price6.515.467.897.6241.2
Benchmark*4.44.247.633.167.4

Sources: BlackRock and Datastream

*With effect from 22 March 2018 the Numis Smaller Companies plus AIM (excluding Investment Companies) Index replaced the Numis Smaller Companies excluding AIM (excluding Investment Companies) Index as the Company’s benchmark. The performance of the indices have been blended to reflect this.

At month end
Net asset value capital only:1,000.57p
Net asset value incl. income:1,005.80p
Share price1,026.00p
Premium to cum income NAV2.0%
Net yield1:1.0%
Total Gross assets2:£988.6m
Net market exposure as a % of net asset value3:117.0%
Ordinary shares in issue4:98,289,818
2020 ongoing charges (excluding performance fees)5,6:0.60%
2020 ongoing charges ratio (including performance fees)5,6,7:1.60%

1. Calculated using the 2021 interim dividend declared on 26 July 2021 and paid on 27 August 2021, together with the 2020 final dividend declared on 10 February 2021 and paid on 1 April 2021.

2. Includes current year revenue and excludes gross exposure through contracts for difference.

3. Long exposure less short exposure as a percentage of net asset value.

4. Excluding 0 shares held in treasury.

5. Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 30 November 2020.

6. With effect from 1 August 2017 the base management fee was reduced from 0.70% to 0.35% of gross assets per annum.

7. Effective 1st December 2017 the annual performance fee is calculated using performance data on an annualised rolling two year basis (previously, one year) and the maximum annual performance fee payable is effectively reduced to 0.90% of two year rolling average month end gross assets (from 1% of average annual gross assets over one year). Additionally, the Company now accrues this fee at a rate of 15% of outperformance (previously 10%). The maximum annual total management fees (comprising the base management fee of 0.35% and a potential performance fee of 0.90%) are therefore 1.25% of average month end gross assets on a two-year rolling basis (from 1.70% of average annual gross assets).

Sector Weightings % of Total Assets
Industrials31.7
Consumer Discretionary21.8
Financials18.5
Technology8.4
Consumer Staples7.3
Health Care5.4
Telecommunications3.5
Basic Materials1.7
Net current assets 1.7
-----
Total100.0
=====
Country Weightings% of Total Assets
United Kingdom91.1
United States7.0
France0.9
Australia0.7
Sweden0.7
Israel-0.1
Germany-0.3
-----
Total100.0
=====

Market Exposure (Quarterly)
30.11.20 %28.02.21 %31.05.21 %31.08.21 %
Long120.4126.8121.3119.4
Short1.91.51.52.4
Gross exposure122.3128.3122.8121.8
Net exposure118.6125.3119.8117.0

Ten Largest Investments
Company% of Total Gross Assets
Gamma Communications3.2
Electrocomponents3.1
Watches of Switzerland2.7
Oxford Instruments2.6
Impax Asset Management2.5
YouGov2.2
Auction Technology2.2
Sigmaroc2.2
IntegraFin2.0
Pets at Home2.0

Commenting on the markets, Dan Whitestone, representing the Investment Manager noted:

The Company returned 6.0%1 in August, outperforming its benchmark, the Numis Smaller Companies +AIM ex Investment Companies, which returned 4.4%1. The long book continued to be the key driver of outperformance during the month.

Equity markets continued to rise in August as central banks around the world, led by the Federal Reserve, provided reassurance that current supportive monetary policy will continue, which curbed concerns around inflation and a possible taper tantrum. Growing concerns around rising Delta variant cases were more than offset by ongoing positive corporate earnings newsflow, and M&A (Merger & Acquisition) activity remained a key feature of the UK market, with interest from corporate buyers being a key driver of the outperformance of small & mid-caps.

The largest contributor during the period was SigmaRoc, a new purchase for us when we backed a large equity raise for a transformational deal to acquire Nordalk, a privately owned Scandinavian based limestone business. This strategic and highly accretive acquisition transforms SigmaRoc by significantly increasing their European footprint whilst diversifying their end market exposure away from construction. The management team of SigmaRoc have developed a strong track record in acquiring and improving the financial performance of UK and European based heavy side material assets, and we see strong potential for underlying improvements in revenues, profits and cash generation from Nordalk. We are very excited about the future prospects for this company on an organic and inorganic basis. Shares in Auction Technology Group continued to appreciate post the strategic acquisition of Live Auctioneers, announced in July, which we discussed in last month’s update. Specialist pharmaceuticals services business, Ergomed, rose following a good trading update at the end of July, which highlighted positive momentum and trading in-line with recently upgraded guidance.

The largest detractor to performance during the month was Avon Protection which fell after a large profit warning on order delays which the management attribute to a combination of COVID-19 and supply chain disruptions. This is the second negative development in the last twelve months, so whilst disappointing, we think the issues are transitory as opposed to structural. Our view is that the longer-term revenue opportunity for Avon is significant and there is no change in the competitive landscape, therefore Avon will return to revenue and profit growth as they mobilise the contracts that have been delayed and continue to win new ones. 

Overall, a reassuring month from a company update perspective, with strong trading patterns reported and we continue to engage with management teams that exude confidence in their growth prospects. There remains an abundance of investment opportunities for us on both sides of the book and several new long and short ideas have entered the portfolio during the month. More recently it seems company and industry fundamental analysis and the subsequent dispersion in financial outcomes reported in company updates is having a greater impact on share prices, a trend we believe will continue. To conclude, we retain our high conviction in the fundamental strength of many of our differentiated investments and the power and enduring nature of many secular trends we are witnessing right now.

1Source: BlackRock as at 31 August 2021

24 September 2021

ENDS

Latest information is available by typing www.blackrock.com/uk/thrg on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
2nd May 20245:50 pmPRNTransaction in Own Shares
2nd May 20245:26 pmPRNDisclosure of Portfolio Holdings
2nd May 202412:06 pmPRNNet Asset Value(s)
2nd May 20247:00 amPRNTotal Voting Rights
1st May 20246:33 pmPRNTransaction in Own Shares
1st May 202412:05 pmPRNNet Asset Value(s)
1st May 20247:00 amPRNTotal Voting Rights
30th Apr 20245:44 pmPRNTransaction in Own Shares
30th Apr 202412:06 pmPRNNet Asset Value(s)
30th Apr 20247:00 amPRNTotal Voting Rights
29th Apr 20245:51 pmPRNTransaction in Own Shares
29th Apr 20244:59 pmPRNPortfolio Update
29th Apr 202412:24 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 20245:36 pmPRNTransaction in Own Shares
26th Apr 202411:42 amPRNNet Asset Value(s)
26th Apr 20247:00 amPRNTotal Voting Rights
25th Apr 20246:00 pmPRNTransaction in Own Shares
25th Apr 20245:45 pmPRNDirector/PDMR Shareholding
25th Apr 202412:11 pmPRNNet Asset Value(s)
25th Apr 20247:00 amPRNTotal Voting Rights
24th Apr 20245:54 pmPRNTransaction in Own Shares
24th Apr 202412:11 pmPRNNet Asset Value(s)
24th Apr 20247:00 amPRNTotal Voting Rights
23rd Apr 20245:41 pmPRNTransaction in Own Shares
23rd Apr 202412:11 pmPRNNet Asset Value(s)
23rd Apr 20247:00 amPRNTotal Voting Rights
22nd Apr 20245:52 pmPRNTransaction in Own Shares
22nd Apr 202411:52 amPRNNet Asset Value(s)
22nd Apr 20247:00 amPRNTotal Voting Rights
19th Apr 20246:00 pmPRNTransaction in Own Shares
19th Apr 202412:05 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 20246:36 pmPRNTransaction in Own Shares
18th Apr 202412:14 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20245:58 pmPRNTransaction in Own Shares
17th Apr 202412:12 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:45 pmPRNTransaction in Own Shares
16th Apr 202412:00 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:54 pmPRNTransaction in Own Shares
15th Apr 202411:34 amPRNNet Asset Value(s)
15th Apr 20247:00 amPRNTotal Voting Rights
12th Apr 20246:50 pmPRNTransaction in Own Shares
12th Apr 202412:32 pmPRNDirector/PDMR Shareholding
12th Apr 202412:12 pmPRNNet Asset Value(s)
12th Apr 20247:00 amPRNTotal Voting Rights
11th Apr 20245:55 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.